SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
919Complementary whole-genome technologies reveal the cellular response to proteasotnsaf-2/10/2002
918>>SOUTH SAN FRANCISCO, Calif. & KENILWORTH, N.J.--(BUSINESS WIRE)-- Fetuck-2/6/2002
917XNVA,MLNM, Xenova Group plc Anti-Cancer Compound XR11576 Enters Clinical Trialswgh613-2/5/2002
916J.D.K: Todays so called investors do not have time frames of yester years. TheirDoug-2/4/2002
915Millennium Pharmaceuticals Announces Webcast of Presentation at the Merrill LyncSemiBull-1/31/2002
914Arb on the merger is small: -Millennium Pharmaceuticals Inc. (MLNM), Cor Theramopgcw-1/28/2002
9131/22/02 conference call notes 1. 2002 guidance 3-4 nmes in clinic, followed bysoftware salesperson-1/22/2002
912Strong Sales of INTEGRILIN - Eptifibatide - Injection Account for Profitable FouSemiBull-1/22/2002
911<i> 16:44 ET Millennium Pharm (MLNM) 20.23 -0.17: Reports Q4 net loss of tom pope-1/22/2002
910CAMBRIDGE, Mass., Jan. 22 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, nigel bates-1/22/2002
909Tuesday January 22, 4:03 pm Eastern Time Press Release SOURCE: COR Therapeutics,scaram(o)uche-1/22/2002
908>>I see this acquisition as a future major cash drain in addition to the iIcebrg-1/22/2002
907<i>Considering how badly BMY screwed up why should i have more confidence tom pope-1/21/2002
906the last time i read a valuation by a morgan stanley analyst it involved a targeMadharry-1/21/2002
905I have read through the prospectus and I see no compelling reason to approve theMadharry-1/21/2002
904ON24: Biotech earnings preview, analyst expects few surprises biz.yahoo.comSemiBull-1/21/2002
903<i don't like it> No argument here. My only point is that I agree withElmer-1/21/2002
902Madharry I think this acquisition should be looked upon from Millennium's sIcebrg-1/21/2002
901I looked at it but how can anyone have any confidence whatsoever in earnings estMadharry-1/21/2002
900Most of the decline mirrors the BTK, I am voting for the acquisition.jayhawk969-1/21/2002
899Hi Harry, This article provides an explanation for the COR deal. signalsmag.coElmer-1/21/2002
898As a shareholder , I am now asked to vote on this merger- looks like the cost ofMadharry-1/21/2002
897Federal regulators clear Millennium-COR merger CAMBRIDGE, Mass., Jan. 17 (ReuteSemiBull-1/20/2002
896It looks like you made a very well timed purchase. I think the hedge fund gang, Elmer-1/18/2002
895Millennium and COR Therapeutics Receive Early Hart-Scott-Rodino Clearance CAMBRSemiBull-1/17/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):